Experience in switching monoclonal antibodies in a patient with severe refractory atopic dermatitis: from Dupilumab to Abrocitinib. Case report . Rev Alerg Mex [Internet]. 2025 Dec. 19 [cited 2026 Sep. 23];72(4):382-5. Available from: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/1547